SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

Galmed Pharmaceuticals Ltd. (GLMD)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence
Probe Score
1.5 / 10
Letters
1
Latest Activity
Aug. 21, 2025
Version
v1

Score Breakdown

Letter Count
1.0
Sentiment / Tone
0.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Aug. 21, 2025 CORRESP Neutral/Informational Moderate Galmed Pharmaceuticals Ltd. has submitted a request to the SEC for the acceleration of the effectiveness of its Registration Statement No. 333-289703 on Form F-1. The company aims… Read Filing EDGAR
Aug. 20, 2025 UPLOAD Neutral/Informational Low The SEC has communicated to Galmed Pharmaceuticals Ltd. that they will not review the company's registration statement filed on August 18, 2025. The letter emphasizes that the res… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.